Aclaris Therapeutics, Inc. (ACRS) vs CorMedix Inc. (CRMD)
A side-by-side comparison of Aclaris Therapeutics, Inc. and CorMedix Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRS
Aclaris Therapeutics, Inc.
$3.94HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
CRMD
CorMedix Inc.
$7.22HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — ACRS vs CRMD
growth of $100 · dividends reinvested · last 10yACRS -83.0% (-16.2%/yr)CRMD -48.3% (-6.4%/yr)CRMD compounded faster over this window
ACRS CRMD
ACRS vs CRMD: by the numbers
- •CRMD is the larger company ($566M vs $550M market cap).
- •CRMD is profitable (40.49% net margin) while ACRS runs a net loss (-921.50%).
- •CRMD grew revenue faster over the past five years (352.03% vs 4.39% CAGR).
Metrics side by side
Valuation
| Metric | ACRS | CRMD |
|---|---|---|
| P/E ratio | N/A | 3.39 |
| Forward P/E | N/A | 14.58 |
| P/S ratio | 66.93 | 1.23 |
| P/B ratio | 4.42 | 1.23 |
| EV / EBITDA | N/A | 1.80 |
| FCF yield | N/A | 44.18% |
Profitability
| Metric | ACRS | CRMD |
|---|---|---|
| Gross margin | 73.28% | 82.78% |
| Operating margin | -975.91% | 46.95% |
| Net margin | -921.50% | 40.49% |
| ROE | -60.79% | 40.62% |
| ROIC | -56.99% | 27.87% |
Growth (annualized)
| Metric | ACRS | CRMD |
|---|---|---|
| Revenue CAGR (5Y) | 4.39% | 352.03% |
| Total return CAGR (5Y) | -24.23% | 9.70% |
Frequently asked
- Which has grown faster, ACRS or CRMD?
- Over the past five years, CRMD grew revenue faster — ACRS at a 4.39% CAGR versus CRMD at 352.03%.
- Is ACRS or CRMD more profitable?
- CRMD runs the higher net margin — ACRS at -921.50% versus CRMD at 40.49%.
- How have ACRS and CRMD total returns compared?
- Over the past 10 years, ACRS delivered -16.23% and CRMD delivered -7.74% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CorMedix P/E ratioAclaris Therapeutics ROECorMedix ROEAclaris Therapeutics operating marginCorMedix operating marginAclaris Therapeutics revenue growthCorMedix revenue growthAclaris Therapeutics free cash flowCorMedix free cash flow
Aclaris Therapeutics & CorMedix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.